COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 190 filers reported holding COHERUS BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,253,000 | +12.3% | 293,538 | +79.9% | 0.17% | +6.9% |
| Q1 2023 | $1,116,000 | -51.3% | 163,140 | -48.4% | 0.16% | -53.4% |
| Q2 2022 | $2,291,000 | -53.8% | 316,455 | -17.6% | 0.34% | -44.4% |
| Q1 2022 | $4,958,000 | -39.6% | 384,010 | -25.4% | 0.62% | -41.0% |
| Q4 2021 | $8,210,000 | +1.2% | 514,438 | +1.9% | 1.04% | +1.9% |
| Q3 2021 | $8,114,000 | +133.4% | 504,936 | +100.9% | 1.03% | +134.2% |
| Q2 2021 | $3,476,000 | +18.0% | 251,358 | +24.7% | 0.44% | +12.9% |
| Q1 2021 | $2,946,000 | +65.2% | 201,628 | +96.5% | 0.39% | +42.1% |
| Q4 2020 | $1,783,000 | -21.2% | 102,615 | -16.9% | 0.27% | -29.8% |
| Q3 2020 | $2,264,000 | +6.1% | 123,462 | +3.3% | 0.39% | +2.6% |
| Q2 2020 | $2,134,000 | +1.3% | 119,516 | -8.0% | 0.38% | -10.6% |
| Q1 2020 | $2,106,000 | +3.0% | 129,859 | +14.4% | 0.42% | +72.4% |
| Q4 2019 | $2,044,000 | – | 113,548 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |